| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.28 | 0.05 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.06 |